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Post-translational modiﬁcation of protein serines/threo-
nines with N-acetylglucosamine (O-GlcNAc) is dynamic,
inducible and abundant, regulating many cellular
processes by interfering with protein phosphorylation.
O-GlcNAcylation is regulated by O-GlcNAc transferase
(OGT) and O-GlcNAcase, both encoded by single, essential,
genes in metazoan genomes. It is not understood how OGT
recognises its sugar nucleotide donor and performs
O-GlcNAc transfer onto proteins/peptides, and how the
enzyme recognises speciﬁc cellular protein substrates.
Here, we show, by X-ray crystallography and mutagenesis,
that OGT adopts the (metal-independent) GT-B fold and
binds a UDP-GlcNAc analogue at the bottom of a highly
conserved putative peptide-binding groove, covered by a
mobile loop. Strikingly, the tetratricopeptide repeats
(TPRs) tightly interact with the active site to form a
continuous 120A ˚ putative interaction surface, whereas
the previously predicted phosphatidylinositide-binding
site locates to the opposite end of the catalytic domain.
On the basis of the structure, we identify truncation/point
mutants of the TPRs that have differential effects on
activity towards proteins/peptides, giving ﬁrst insights
into how OGT may recognise its substrates.
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Introduction
Serines/threonines on nucleoplasmic proteins in metazoans
can be post-translationally modiﬁed with N-acetylglucosa-
mine (O-GlcNAc) (Torres and Hart, 1984). This is an abun-
dant, dynamic and inducible modiﬁcation, regulating a wide
range of cellular processes, such as the cell cycle, transcrip-
tion, the insulin response and proteasomal degradation (Love
and Hanover, 2005; Hart et al, 2007). There is a considerable
body of evidence to suggest that O-GlcNAc may regulate
cellular protein phosphorylation by competing for the same
serines/threonines (Hart et al, 1995, 2007; Love and Hanover,
2005). However, in striking contrast to protein phosphoryla-
tion, dynamically regulated by over 500 kinases and 150
phosphatases, O-GlcNAcylation is balanced by a single, in-
verting O-GlcNAc transferase (OGT) and a single O-GlcNAc
hydrolase (Haltiwanger et al, 1992; Gao et al, 2001). The
genes for these proteins are highly conserved and essential in
metazoans (Hanover et al, 2005; Hart et al, 2007). Despite the
discovery and characterisation of OGTover two decades ago,
the molecular mechanisms by which it recognises its protein
substrates and transfers O-GlcNAc from the UDP-GlcNAc
donor are not understood. Early sequence analyses suggested
the presence of two conserved domains, CDI/II, separated by
a linker (Lubas et al, 1997; Roos and Hanover, 2000), and it
has also been demonstrated that OGT is a metal-independent
glycosyltransferase (Kreppel et al, 1997; Lubas and Hanover,
2000). Unlike the protein kinases, which often possess
exquisite speciﬁcity towards precise peptide sequences, no
O-GlcNAcylation sequence motif has so far been discovered.
In addition to recognition of protein/peptide substrates, OGT
has very recently been shown to bind to phosphatidylinosi-
tides (PIs) at the plasma membrane, which is required for
O-GlcNAcylation of protein kinase B, a key node in the
insulin signalling pathway (Yang et al, 2008).
OGT possesses an unusual N terminus, consisting of
2.5–13.5 tetratricopeptide repeats (TPRs) depending on alter-
native splicing (Kreppel and Hart, 1999). Elegant truncation
and competition experiments have demonstrated that,
although not essential for short peptide substrates, these
TPRs have some function in the recognition of intact protein
substrates (Lubas and Hanover, 2000; Iyer and Hart, 2003). A
structure of some of the N-terminal repeats revealed how
these form a superhelix with a large concave surface, pro-
posed to represent the substrate-binding groove (Jinek et al,
2004). However, the molecular mechanisms through which
these TPRs contribute to O-GlcNAc transfer are not under-
stood.
Here, using X-ray crystallography and structure-guided
mutagenesis, we provide the ﬁrst molecular insights into
the structure of OGT, how it binds UDP-GlcNAc and aligns
it for inverting O-GlcNAc transfer, and reveal that the TPRs
are not a separate domain, but intimately associated with the
active site groove, forming an extended and highly conserved
putative interaction surface extending over 120A ˚. We identify
TPR truncations and substrate groove point mutants of OGT
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2780that dissect the balance between recognition of peptides in
the active site groove of about 35A ˚ and protein substrates by
the more extended surface formed by the TPRs. The OGT
structure shows that recently identiﬁed mutations that
disrupt PI binding locate to a solvent-exposed pocket on the
catalytic domain. This work provides a molecular framework
for further studies towards OGT speciﬁcity and for the
discovery/interpretation of novel OGT inhibitors.
Results and discussion
OGT adopts a GT-B fold
The CAZy database (Coutinho et al, 2003) shows that human
OGT (hOGT) is predicted to adopt the GT41 fold, for which
there are currently no known structures. To determine the
OGT structure, we cloned, overexpressed and puriﬁed an
apparent OGT orthologue from Xanthomonas campestris
(XcOGT). This protein is 36% identical to the hOGTsequence
in the catalytic core and in addition contains three apparent
TPRs (Figure 1). Native XcOGT crystals diffracted to 2.1-A ˚
resolution, and phases were obtained with a seleno-methio-
nine (SeMet) derivative (Table I; Supplementary Figure 1).
Iterative model building and reﬁnement yielded a ﬁnal model
with good reﬁnement statistics (R¼0.194, Rfree¼0.237;
Table I). Soaking experiments with a phosphonate analogue
of UDP-GlcNAc yielded a complex at 2.5A ˚ resolution
(R¼0.217, Rfree¼0.258; Table I).
The XcOGT structure reveals three distinct domains, con-
served in hOGT (Figures 1 and 2). At the N terminus, three
complete TPR repeats form the standard TPR superhelix
(Kusuda et al, 1998; D’Andrea and Regan, 2003), followed
by another two pairs of antiparallel a-helices, termed the
TPR-like repeats (TLRs; green in Figure 2) continuing the
superhelix. At the C terminus, two similar a/b-folds are
observed, with the UDP-GlcNAc-binding site formed at the
interface between these domains. Previous bioinformatics
analysis proposed two separate catalytic/substrate-binding
domains (CDI/II) (Roos and Hanover, 2000). However, struc-
ture searches with DALI (Holm and Sander, 1993) reveals that
CDI/II of XcOGT, and thus the GT41 family, in fact form a
single catalytic domain of the GT-B fold frequently observed
in GTs (Davies et al, 2005). Examples of inverting GT-B GTs
adopting similar overall folds are MurG (Hu et al, 2003)
(RMSD on 260 equivalent Cas¼4.4A ˚; see Supplementary
Figure 2) and b-glucosyltransferase (Larivie `re et al, 2003)
(RMSD on 230 equivalent Cas¼3.3A ˚). Whereas GTs adopt-
ing the GT-A fold are metal-dependent enzymes, GT-B GTs are
metal-independent (Davies et al, 2005). There is no evidence
for metal coordination in the XcOGTactive site, and hOGT is
active in the absence of exogenous divalent cations or in the
presence of excess EGTA (Figure 3A).
The high sequence identity of XcOGT with the well-
characterised OGTs from human (Haltiwanger et al, 1992),
Caenorhabditis elegans (Hanover et al, 2005) and Xenopus
laevis (Figure 1) allows us to interpret sequence conservation
of these metazoan OGTs in the framework provided by the
XcOGT structure (Figure 2), revealing a number of striking
features. Not only is the area immediately surrounding the
UDP-GlcNAc-binding site conserved, but also a path of high
sequence conservation is observed from the active site
groove, where the O-GlcNAc acceptor peptides are expected
to bind, all the way into the TPR repeats, which have been
shown to be important for substrate speciﬁcity (Lubas and
Hanover, 2000; Iyer and Hart, 2003). Although sequence
identity throughout the catalytic core is high, it is apparent
that the metazoan OGTs contain an extra, rather variable,
loop of approximately 110 residues between the two lobes of
the GT-B fold, approximately 20A ˚ away from the active site
Figure 1 OGT sequence conservation. Alignment of OGT sequences from Xanthomonas campestris pv. campestris (XcOGT), Caenorhabditis
elegans (CeOGT), Xenopus laevis (XlOGT) and human (hOGT, isoform 1). N termini of hOGT constructs are indicated by arrows. Secondary
structure elements (cylinders/arrows) are shown, a brown bar marks the active site lid. coloured bars indicate the TPRs (yellow¼A helix;
orange¼B helix), the TLRs (green), the connecting loop (light green), the N-terminal GT-B subdomain (cyan), the intersubdomain linker (blue)
and the C-terminal GT-B subdomain (magenta). Blue triangles give the location of the previously described (triangle up) and proposed
additional (triangle down) PIP3-interacting residues, orange and red circles locate point mutations described previously and in the present
work, respectively. Labels represent hOGT/XcOGT residues.
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Seleno-methionine Apo UDP-GlcNAc analogue complex
Unit cell (A ˚) a¼86.21 a¼81.52 a¼83.86
b¼101.44 b¼100.10 b¼100.53
c¼155.58 c¼156.27 c¼154.52
Resolution (A ˚) 20.00–3.1 (3.21–3.1) 20.00–2.10 (2.17–2.10) 20.00–2.50 (2.59–2.50)
No. of observed reﬂections 377707 (35172) 300426 (27295) 188629 (18052)
No. of unique reﬂections 25333 (2359) 70020 (6362) 43895 (4201)
Redundancy 14.9 (7.9) 4.3 (4.3) 4.3 (4.0)
I/sI 20.8 (3.3) 14.8 (4.0) 10.2 (2.7)
Completeness (%) 99.4 (94.4) 93.5 (86.1) 95.1 (92.5)
Rmerge 0.167 (0.651) 0.094 (0.471) 0.103 (0.389)
R, Rfree 0.194 (0.237) 0.217 (0.258)
RMSD from ideal geometry
Bonds (A ˚) 0.016 0.017
Angles (deg) 1.63 1.79
B-factor RMSD (A ˚2)
Backbone bonds 0.74 0.49
oB4 (A ˚2)
Protein (no. of atoms) 39.4 (8355) 26.9 (8366)
Ligand (no. of atoms) NA 34.8 (78)
Solvent (no. of atoms) 41.8 (321) 21.5 (148)
Values between parentheses are for the highest resolution shell. All measured data included in structure reﬁnement. All crystals were of space
group P212121.
File translated from TEXb yT TH, version 3.67 on 31 July 2008, 1833 hours.
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Figure 2 Structure of OGT. (A) Cartoon view of XcOGT in complex with the UDP-GlcNAc analogue, using the domain colours as described in
Figure 1. Beyond the XcOGT N-terminal TPRs, the TPR superhelix is continued by the superimposed hOGT TPR structure (PDB id, 1W3B,
semitransparent). The phosphoinositide-binding site is identiﬁed by an IP4 model obtained by superposition as explained in the text. Mutated
and PIP3-binding side chains (colours as in Figure 1) are shown as sticks and labelled with XcOGT residue numbers, the equivalent hOGT
residue numbers can be obtained from Figure 1. The UDP-GlcNAc analogue is shown with green carbons. The OGT middle domain is indicated
by the ‘OMD’ label. (B) Surface representation of the XcOGT/hOGT superposition, coloured by metazoan OGT sequence conservation (blue
(100% identity) to white (o50%)).
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predictions suggest an a/b-fold. Although its structure/func-
tion remains to be established, it is possible that it could
contribute to the relative orientations of the two lobes of the
GT-B fold or perhaps acceptor substrate speciﬁcity.
A landmark study has recently revealed that hOGT trans-
locates to the membrane and O-GlcNAcylates protein kinase
B in a phosphatidylinositol(3,4,5)trisphosphate (PIP3)-de-
pendent manner (Yang et al, 2008). A double mutant of two
lysines, identiﬁed by lysine-scanning mutagenesis, was
shown to be deﬁcient in PIP3 binding and membrane trans-
location. The XcOGT structure reveals that these lysines are
located on the ridge of a pocket on the surface of the OGT
structure (Figure 2). This pocket is well conserved in me-
tazoan OGTs and is surrounded by further, conserved, basic
residues (Arg822, Arg991 and Arg984; Figures 1 and 2). In
structurally characterised phosphoinositide-binding domains,
a similar arrangement is observed, with a pocket surrounded
by basic residues, interacting with the phosphate groups
(Lemmon, 2003). Indeed, a structural comparison of the
OGT side chain positions to those of all known protein–
phosphoinositide complexes produces several good matches
(down to RMSD¼1.9A ˚ on 5 Ca positions), allowing
approximate placement of a phosphoinositide in this
pocket (Figure 2). This pocket is located away from the
active site and TPRs; its position would thus be compatible
with the PIP3-dependent O-GlcNAcylation of protein
substrates such as protein kinase B (Yang et al, 2008)
(Figure 4B).
OGT possesses a conserved UDP-GlcNAc-binding
pocket
Soaking experiments of XcOGT crystals with a UDP-GlcNAc
phosphonate analogue revealed it to be bound in an elon-
gated cleft (Figures 2 and 4A). UDP is tethered through
backbone hydrogen bonds, a hydrogen bond to the ribose
and several basic residues interacting with the phosphates.
The sugar is inserted between three loops, burying the
N-acetyl group, while leaving the b-face of the pyranose
ring partially solvent exposed, compatible with the inverting
nature of the enzyme (an ordered water molecule is within
3.4A ˚ from the anomeric carbon). One of these loops (the
‘active site lid’) is partially disordered and assumes different
conformations in the apo/complex structures, partially (un)-
covering the site of nucleophilic attack (shifts up to 11A ˚;
Figure 4A). Interestingly, a tyrosine hydroxyl lies near the
anomeric carbon, closely interacting with a nearby lysine.
It is possible that this would allow the tyrosine to function
as a base, activating the peptide substrate serine/threonine
hydroxyl for nucleophilic attack. His466 occupies different
conformations in the apo structure and the UDP-GlcNAc
phosphonate complex, interacting with the phosphates in
the latter, and may participate in stabilisation of the leaving
group. A number of experimental data are available to
support the observed UDP-GlcNAc-binding mode and the
proposed mechanism of attack. Screening of mutant collec-
tions to identify inactivating mutants of spy, one of the plant
OGT orthologues, showed that three of these (mapping
to XcOGT D288, G291 and G293; Silverstone et al,2 0 0 7 )
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Figure 3 Mutational analysis and substrate speciﬁcity of OGT. (A) hOGT (overexpressed and puriﬁed from baculovirus) was incubated with
the protein substrate TAB1 in the absence of magnesium and in the presence of 1mM EGTA, and the reaction mixture was probed by anti-O-
GlcNAc western blotting. (B) Single-point hOGT mutants (overexpressed and puriﬁed from E. coli) localised in the putative peptide and UDP-
GlcNAc-binding site assayed against TAB1 and studied by anti-O-GlcNAc western blotting. (C, D, E) Activity assay of the truncated
baculovirally expressed hOGT constructs against different acceptor substrates. (C) Immunoblot detecting O-glycosylated TAB1, (D)
O-glycosylated HEK293 lysates and (E) radioactivity assay against the CKII peptide. (F) Anti-O-GlcNAc immunoblot of Arabidopsis thaliana
lysate incubated with XcOGT and UDP-GlcNAc shows one single protein substrate around 130kDa.
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active site lid loop that controls access to the b-face of the
sugar (Figures 2A and 4A). Furthermore, two studies have
reported inactivating point mutants of hOGT, with one of
these (mapping to XcOGTA314) lying on the tip of a loop near
the sugar (Figure 4A; Lazarus et al, 2005). Another reported
mutant maps to XcOGT D471, which hydrogen bonds the
UDP ribose (Figure 4A; Yang et al, 2008). Most of these
mutants involve residues that are conserved (Figure 1). We
used additional mutagenesis in hOGT to test the UDP-
GlcNAc-binding mode and the putative catalytic mechanism.
Interactions with the sugar were probed through mutation
T560A, which showed signiﬁcantly reduced activity
(Figure 3B). The K842M/Q839A point mutants were designed
to disrupt interactions with the phosphates and indeed their
activity is almost abrogated (Figure 3B). Similarly, the hOGT
D925A/K898A mutants of residues that interact with the
nucleoside show no detectable activity compared with the
wild-type enzyme. An independent experiment with the
hOGT D925N mutant expressed in a baculovirus system
yielded similar results (see Supplementary Figure 3).
Thus, the binding mode of the UDP-GlcNAc phosphonate
analogue is in agreement with the mutagenesis data,
although we were unable to conﬁrm proper folding for all
the inactive mutants.
The TPRs closely associate with the active site
Extensive previous work has shown that the TPRs of OGTare
important for recognition of large protein substrates (Lubas
and Hanover, 2000; Iyer and Hart, 2003). The structure of the
N-terminal 11.5 TPRs of hOGT has been solved, revealing a
superhelical structure, with asparagines on the concave sur-
face proposed to be important for recognition of nucleoporins
(Jinek et al, 2004). Sequence alignment of XcOGTwith hOGT
provides a mechanism for structural alignment of the TPRs
with conservation of the canonical TPR sequence motif
(Figures 1 and 2). The XcOGT structure reveals that the
three complete XcOGT repeats, corresponding to repeats 11–
13 in the human sequence, closely associate with, indeed
form part of, a highly conserved substrate-binding groove
near the active site (Figure 2). Although soaking studies with
model OGT substrate peptides were unsuccessful, the elon-
gated nature of the groove on the catalytic domain (approxi-
mately 35A ˚) suggests peptides may bind in an extended
conformation.
The position of the TPRs is very different from the majority
of TPR-containing proteins, where the TPRs are usually
associated with the main domain through a ﬂexible linker
(D’Andrea and Regan, 2003), with the notable exception of
protein phosphatase 5, where close association of the TPRs
with the active site provides a mechanism for autoinhibition
(Yang et al, 2005) (Figure 4C). Repeats 1–10 in hOGT project
away from the active site. Strikingly, the central axis of the
TPR superhelix points towards the sugar nucleotide in the
active site (Figure 2A). This could provide a mechanism by
which an elongated peptide is recognised by more than one of
the TPRs while being bound in the active site groove, as has
been suggested for other TPR proteins (D’Andrea and Regan,
2003). Interestingly, OGT is thought to dimerise, and residues
on the convex surface of the TPRs have been shown to be
involved in the dimerisation surface, and the hOGT TPR
superhelix crystallised as a dimer (Jinek et al, 2004).
However, if we use the hOGT TPR superhelix dimer as a
superposition template, the resulting superposition shows the
GT-B folds and the associated active sites facing away from
each other, suggesting no obvious steric restrictions to the
active site imposed by the TPRs in the dimer (Supplementary
Figure 4).
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Figure 4 OGTactive site and schematics of the TPR interactions. (A) Stereo representation of the active site of XcOGT, with the UDP-GlcNAc
analogue (green carbons) and an omit map (blue, 2.25s). The protein backbone is shown as coil in domain colours as above, amino acids of
interest are shown as sticks, coloured red/orange if they correspond to described point mutants in hOGT; labels as in Figure 2A. Black dotted
lines indicate potential hydrogen bonds. The ‘active site lid’ is shown in both its apo- (brown) and ligand-bound conformation (cyan). A black
arrow indicates the proposed direction of nucleophilic attack compatible with an inverting mechanism. (B) Model of how hOGTand protein
kinase B (an OGTsubstrate) could colocalise in a PIP3-dependent manner on the plasma membrane, as suggested by a recent study (Yang et al,
2008). The OGTactive site is identiﬁed by a sticks model of the sugar donor. (C) Cartoon representation of the OGTcatalytic domain (colours as
in (A, B)) and the different possible models of how the TPRs (rods) might contribute to the regulation of OGTactivity, as seen in other TPR
proteins, such as the widely used ‘substrate localisation mode’ seen in most TPR proteins (D’Andrea and Regan, 2003) and the ‘autoinhibition
mode’ seen in protein phosphatase 5 (Yang et al, 2005). The crystal structure appears to be most compatible with the ‘substrate-binding mode’,
with the TPRs tightly associated with, but not occluding, the active site.
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N-terminal TPRs affects activity of OGTs towards most pro-
tein substrates, whereas deletion of 3–6 TPRs results in an
enzyme that is active against short peptides only (Lubas and
Hanover, 2000; Iyer and Hart, 2003). Analysis of metazoan
OGT sequence conservation in the context of the available
structural data provides an explanation for this. Although the
active site, the putative peptide-binding groove and the last
few TPR repeats possess a highly conserved surface, the
concave surface of the ﬁrst 3–4 TPR repeats is not well
conserved (Figure 2B). This suggests that the OGTs have an
evolutionarily conserved mechanism for recognising protein
sequences close to the site of O-GlcNAc transfer, whereas
different mechanisms of protein substrate recognition have a
function in the terminal TPRs. To investigate this further, we
designed three hOGT truncation mutants based on the struc-
tural data (Figure 1). D8OGT lacks the ﬁrst eight TPR repeats,
whereas the remaining TPRs in the D10.5OGT truncation
approximately correspond to the TPRs observed in the
XcOGT structure (Figures 1 and 2). Finally OGTcat covers
the catalytic domain only. When tested against TAB1, a key
member of the TGFb signalling pathway that we recently
discovered to be an in vitro/in vivo OGTsubstrate (Pathak and
van Aalten, 2008), these truncation mutants show that all but
the last 2.5 TPR repeats are indispensable for recognition of
TAB1 (Figure 3C). This pattern is repeated when total
HEK293 cell lysate is used as acceptor substrate, showing a
reduction in activity towards protein substrates when the ﬁrst
8 TPRs are removed, whereas the last 2.5 TPR repeats are
essential for recognition of protein substrates (Figure 3D).
However, activity against a short peptide substrate is still
detected even in the absence of any TPRs (Figure 3E).
Furthermore, only when the ﬁrst 10.5 TPR repeats are re-
moved does OGT display signiﬁcant self-glycosylation
(Figure 3E). These data are in agreement with the structure,
suggesting that the conserved substrate-binding groove near
the sugar nucleotide is important for peptide binding, the
TPRs near the active site are indispensable for activity
towards all protein substrates, whereas the TPRs nearer the
N terminus could contribute to recognition of speciﬁc
proteins.
To further test the contribution of the last few TPRs and
TLRs, we mutated residues on the conserved surfaces close to
the active site and studied differences in self-glycosylation
and activity towards TAB1 (Figure 3B). Strikingly, the point
mutations D431A/N458A in hOGT, which line the concave
surface of the TPRs/TLRs, do not inactivate the enzyme, as
evidenced by abundant self-glycosylation, but no longer
glycosylate the protein substrate TAB1. In contrast, the
H498A/R637A mutations, located in the putative peptide-
binding groove immediately adjacent to the active site, not
only remove activity towards TAB1 but also abrogate self-
glycosylation (Figure 3B). This is the ﬁrst example of point
mutations that dissect OGT’s intrinsic O-GlcNAc transfer
activity from recognition of a large protein substrate.
In most TPR-containing proteins, ﬂexibly attached TPRs
serve to associate (with) protein partners/substrates
(D’Andrea and Regan, 2003) (the ‘substrate localisation
model’; Figure 4C). Intriguingly in protein phosphatase 5,
close association of the TPR repeats with the active site
provides a mechanism for autoinhibition (Yang et al, 2005)
(the ‘autoinhibition model’). It is clear that OGT represents
another case, where the TPRs integrate with the active site
and also serve to capture large substrates (the ‘substrate-
binding model’; Figure 4C). Interestingly, however, it has also
been reported that a truncated form of hOGT retaining only
three TPRs, exerts an effect as a dominant-negative inhibitor
of other OGT isoforms, and recognises only a single protein
substrate (Lazarus et al, 2005).
Functional characterisation of XcOGT
Although most of the substrate-binding residues are con-
served between XcOGT and the metazoan enzymes
(Figure 1), we could not detect activity for the bacterial
enzyme against bacterial and human cell lysates or short
peptide substrates. To conﬁrm that this protein would indeed
be able to bind sugar nucleotides, we used surface plasmon
resonance to establish a Kd of 4.2mM for UDP-GlcNAc (data
not shown), which is similar to the UDP-GlcNAc Km values
reported for hOGT (Kreppel and Hart, 1999; Lubas and
Hanover, 2000). Interestingly, X. campestris pv. campestris
is a phytopathogen of crucifers, such as Arabidopsis, invad-
ing leaf cells with the aid of virulence factors secreted
through a type III secretion system. Surprisingly, we found
that XcOGT O-GlcNAcylates a single substrate in Arabidopsis
thaliana cell lysates (Figure 3F), demonstrating that this is
indeed an active OGT. Future identiﬁcation of this substrate
may give new insights into the function of bacterial OGTs.
Interestingly, this restricted activity of XcOGTwith its limited
number of TPRs has resonance with the observation that a
truncated form of hOGTretaining only three TPRs recognises
only a single protein substrate (Lazarus et al, 2005).
Furthermore, the hOGT TPR truncation mutants reported
here suggest an important function for the TPRs proximal
to the active site in the recognition of the large protein
substrate TAB1. Further studies with protein/peptide sub-
strates in complex with OGT will be required to unravel the
mechanisms of substrate recognition.
Materials and methods
Synthesis of UDP-GlcNAc phosphonate analogue
Synthesis of GlcNAc-1P phosphonate analogue was accomplished
starting from the known dimethyl (2,3-O-isopropylidene-4,6-di-O-
benzyl-a-D-mannopyranosyl) methanephosphonate (Borodkin et al,
2004) using an adaptation of published methods (Casero et al, 1996;
Chang et al, 2006; Hajduch et al, 2008). In essence, after cleavage of
the isopropylidene protection, the 3-OH group was selectively
benzoylated through a dibutylstannylene intermediate. The result-
ing monohydroxylic compound was transformed into a 2-oxime
derivative upon oxidation followed by reaction with hydroxyla-
mine. Reduction of the oximino function with NaBH3CN in acidic
methanol and hydrogenolytic reduction of the intermediate hydro-
xylamine in the presence of acetic anhydride afforded a separable
mixture of 2-N-acetylamino gluco- (64%) and mannosyl methane-
phosphonates (12%). After swapping of all hydroxyl protective
groups for acetates, the conﬁguration of the major product was
assigned as a-D-gluco using NMR spectroscopy. After removal of all
but the nitrogen protecting groups (TMSBr then MeONa–MeOH),
the resulting GlcNAc-1P phosphonate analogue was efﬁciently
coupled with N-methylimidazolide UMP according to a recently
developed procedure (Marlow and Kiessling, 2001) to furnish the
targeted UDP-GlcNAc phosphonate analogue as ammonium salt in
67% yield after size-exclusion chromatography. Comparison of the
500MHz
1H and
31P NMR spectra of the ﬁnal compound with those
published by others (Gordon et al, 2006) revealed good correlation
of chemical shifts and coupling patterns.
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X. campestris OGT (XcOGT) coding sequence (accession: XCC0866)
was ampliﬁed by PCR from genomic DNA extracted from
X. campestris pv. campestris str. ATCC 33913 using the forward
primer 50-CTGGATCCATGACCGCCGACGGCCCGCGCGAGC-30 and
the reverse primer 50-AACTCGAGCTAAATTCCCAACCAACCATGA
CGCCGCGCG-30, exploiting the BamHI and XhoI restriction sites, for
cloning into pGEX 6P-1 (GE Healthcare). hOGT (UniProtKB/Swiss-
Prot O15294) is encoded by a single gene (NCBI GeneID: 8473)
producing three isoforms by alternative splicing. All positional
information throughout this paper refers to isoform 1 (UniProt
O15294-3). The DNA sequence encoding amino-acid residues 16–
1036 was obtained by PCR from IMAGE EST clone 5017795 using
the forward primer 50-CTGGATCCGAGTTGGCACATCGAGAATAT
CAGGC-30, and the reverse primer 50-CTGCGGCCGCTTATGCTGACT
CAGTGACTTCAACAGGC-3, and cloned, using the BamHI and NotI
restriction sites, into a version of the baculovirus protein expression
vector pFastBac1 (Invitrogen), which had been modiﬁed by
inserting the coding sequence for glutathione S-transferase (GST)
followed by a PreScission protease cleavage site, resulting in the N-
terminal GST fusion construct pFastBac-GST hOGT E16-end.
Generation of N-terminal GST fusions of D8hOGT, D10.5hOGT and
hOGTcat (Figure 1) for expression in the baculovirus system
followed the same cloning strategy following PCR ampliﬁcation
from the aforementioned IMAGE clone using the forward primers
50-CTGGATCCCTACAACCACATTTCCCTGATGCTTACTG-30 (D8hOGT,
starting at residue L278), 50-CTGGATCCATGCATTATAAGGAG
GCTATTCGAATCAGTCC-30 (D10.5hOGT starting at residue M372)
and 50-CTGGATCCGTGCATCCTCATCATAGTATGCTATATCCTC-30
(hOGTcat starting at residue S494), respectively, with the hOGT
reverse primer shown above. The PCR products were cloned into
pFastBac-GST as above.
To generate a bacterial expression construct of D10.5hOGT, an
Escherichia coli codon-modiﬁed synthetic construct was made (Top
Gene Technologies, Toronto) and cloned into the pGEX 6P-1 vector.
Similar to the baculovirus D10.5 TPR hOGTexpression construct, this
plasmid contained the coding sequence for residues M372-A1036 of
hOGT. This plasmid also served as the template for generation of
amino-acid substitutions by site-directed mutagenesis. Mutated
hOGT constructs with the following amino-acid substitutions were
created: D431A, N458A, H498A, H558A, T560A, Y632A, R637A,
R822S, Q839A, Y841F, K842M, K898A, H920A, D925A, R984S and
R991S. Site-directed mutagenesis was carried out throughout
following the QuikChange Site-Directed Mutagenesis protocol
(Stratagene), using the KOD HotStart DNA polymerase (Novagene).
All plasmids were veriﬁed by sequencing.
Expression and puriﬁcation
The XcOGT-pGEX-6P-1 construct was transformed into E. coli BL21
(DE3) pLysS cells. A Minifors fermenter (Infors) containing 3.6l of
autoinduction mediaþampicillin was inoculated with 36ml of
cells. These were then grown for 48h at 251C, 600r.p.m. with a
constant air supply. The cells were harvested by centrifugation at
2250g for 30min, and washed in LB before being resuspended in
lysis buffer (50mM bicine pH 8.5, 150mM NaCl, 1mM DNAse-1,
0.1mM lysozyme, 0.05% (v/v) b-mercaptoethanol, 0.1mM PMSF,
1mM benzamidine and 0.1mM leupeptin) and lysed using a
continuous ﬂow cell disruptor (Constant Systems) at 30kPSI. The
lysate was centrifuged at 40000g, the supernatant was incubated
with glutathione Sepharose 4B beads (GE Healthcare) for 2h at 41C
on a rotating platform. The beads were then washed and incubated
with PreScission Protease (200mg protease per ml of beads) at 41C
for 16h in buffer. The supernatant from beads and a subsequent
wash were passed over a Bio-Rad 20ml disposable column to
remove the beads. This was spin concentrated to 5ml. XcOGT was
further puriﬁed on a Superdex-75 26/60 column (GE Healthcare)
equilibrated against 50mM bicine pH 8.5 and 150mM NaCl. For
assay work, the protein was dialysed against 25mM Tris pH 7.5 and
150mM NaCl.
SeMet medium was prepared following the manufacturer’s
instructions (Molecular Dimensions Ltd.). The pGEX-6P-1-XcOGT
vector was transformed into methionine auxotrophic E. coli 834
(DE3). A 100ml starter culture was grown at 371C overnight and
pelleted, washed three times with sterile H2O, and resuspended in
1ml water and inoculated into 1l prewarmed (301C) minimal
media. After 30min, 4ml of 250  concentrate of L-SeMet was
added to the culture. Growth continued for 4h before induction
with 1mM isopropyl b-D-1-thiogalactopyranoside (IPTG) overnight
at 181C. The protein was puriﬁed as described for native protein.
hOGT and mutants thereof were expressed in E. coli and
baculovirus systems. For E. coli expression, the plasmids were
transformed into BL21 (DE3) pLysS cells and plated into LB with
50mg/ml ampicillin. Cells were grown at 371C until OD600¼0.6,
when expression of the protein was induced with 0.2mM IPTG at
161C for an overnight incubation. The cells were harvested by
centrifugation (3480g for 30min) and resuspended in a buffer
(25mM Tris–HCl and 250mM sodium chloride, pH 7.5), containing
lysozyme, DNAse and protease inhibitors. The cells were disrupted
by the continuous ﬂow cell disruptor at a pressure of 30kPSI. and
centrifuged at 40000g at 41C for 30min. The supernatant was
incubated at 41C with pre-washed glutathione Sepharose 4B beads
and the proteins were eluted with 50mM reduced glutathione in the
same buffer. Subsequently, the enzymes were dialysed overnight
into 25mM Tris–HCl, 150mM NaCl, pH 7.5 and then spin
concentrated. For baculovirus expression, constructs were used to
generate recombinant baculovirus using the Bac-to-Bac system (Life
Technologies) following the manufacturer’s protocol. The resulting
baculoviruses were used to infect Sf21 cells at 1.5 10
6/ml. The
infected cells were harvested by centrifugation 48h post-infection.
Cell pellets corresponding to 1–6l of culture were resuspended in
25mM Tris–HCl, 150mM NaCl and 2mM dithiothreitol (DTT) at pH
8.5, containing DNAse and protease inhibitors. The suspension was
rolled at 41C for 30min and lysis was then performed using the
continuous ﬂow cell disruptor (35kPSI). Centrifugation (40000g,
30min) was then carried out. The supernatant was mixed with pre-
washed glutathione Sepharose 4B beads and incubated on a rolling
platform at 41C for 1.5h. The beads were then spun down and
washed with 4  50ml 25mM Tris–HCl, 150mM NaCl and 2mM
DTT, pH 7.8. The enzymes were then cleaved overnight at 41C with
PreScission protease and the supernatants containing the proteins
were then spin concentrated. Gel ﬁltration was carried out on a
Superdex-75 XK26/60 column in 25mM Tris–HCl, 150mM NaCl
and 2mM DTT, pH 8.5. Fractions in the peak containing the protein
were pooled and concentrated.
Structure determination
Puriﬁed XcOGT protein was spin concentrated to 10mg/ml.
Hanging drop vapour diffusion crystallisation experiments were
performed by mixing 1ml of protein, 1ml of mother liquor (0.1M
CHES pH 9.5 and 25% polyethylene glycol 3350) and 0.4ml 100mM
praseodymium acetate. SeMet crystals were grown by mixing 1mlo f
protein with 1ml mother liquor (0.1M CHES pH 9.0 and 27.5% PEG-
3350). To obtain ligand complexes, crystals were soaked with
10mM UDP-GlcNAc phosphonate for 5min. Crystals were cryopro-
tected by a 3-s immersion in mother liquor with increased (40%)
PEG-3350 concentration.
Diffraction data from XcOGT, XcOGT-SeMet and XcOGT-UDP-
GlcNAc analogue crystals were collected with synchrotron radiation
and processed using the HKL suite (Otwinowski and Minor, 1997),
yielding reﬂection ﬁles as summarised in Table I. SOLVE (Terwilli-
ger and Berendzen, 1999) was able to locate 14 selenium sites in the
SAD data set, revealing two-fold non-crystallographic symmetry,
compatible with two molecules in the asymmetric unit as predicted
from the Matthew’s coefﬁcient. Solvent ﬂattening/averaging with
DM (Cowtan, 1994) and RESOLVE (Terwilliger, 2003) yielded an
interpretable 3.1A ˚ experimental map. Aided by real-space searches
with known TPR structures using FFFEAR (Cowtan, 1998), a partial
model was completed with COOT (Emsley and Cowtan, 2004) that
was then rigid-body reﬁned into the native data set. Iterative model
building with COOT and reﬁnement with REFMAC (Murshudov
et al, 1997) yielded a ﬁnal model covering the catalytic core and
TPR repeats (Table I). This was then used as an initial model for
reﬁnement of the UDP-GlcNAc analogue complex. The UDP could
be easily placed in the difference density, but two conformations
appeared to be allowed for the sugar. We have reﬁned the major
conformer, placing the sugar in a conserved pocket at the bottom of
the substrate-binding cleft, as assessed by omit map analysis
(Figure 4A; Table I). In this complex, the active site ‘lid loop’ is
associated with poor electron density, suggesting disorder.
OGT activity assays
The anti-O-GlcNAc antibody CTD110.6 was purchased from Abcam.
An anti-TAB1 antibody was raised in sheep against bacterially
expressed His-TAB1. A GST–HRP antibody was purchased from
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Signaling Technology. Secondary antibodies conjugated to horse-
radish peroxidase were from Pierce.
For western blotting, cells were lysed in lysis buffer containing
50mM Tris–HCl pH 7.5, 150mM NaCl, 0.5% NP40. Protein
concentration was determined by Coomassie protein assay (Pierce).
For immunoblotting, the protein samples were subjected to 10%
SDS–PAGE, transferred to PVDF membrane and blocked with 3%
BSA before incubating with primary antibody and subsequently
with conjugated anti-mouse IgM-HRP. To detect proteins, a
chemiluminescent signal was developed using a GE Healthcare
ECL kit.
Mammalian cell lysate was prepared from HEK293 cells. Cells
were harvested by the removal of the medium followed by lysis in
ice cold buffer A (50mM Tris–HCl pH 7.5, 0.1mM EGTA, 1mM
EDTA, 1% (w/w) Triton X-100, 1mM Na3VO4, 50mM NaF, 5mM
sodium pyrophosphate, 0.27M sucrose, 0.1% (v/v) 2-mercap-
toethanol and proteinase inhibitor cocktail). Protein concentrations
of the lysates were determined using the Bradford method.
Recombinant TAB1 was produced in E. coli as a GST fusion protein.
OGT peptide assays were performed as described earlier (Iyer
and Hart, 2003). The peptide PGGSTPVSSANMM (CKII peptide)
was used for radioactivity assays. The peptide (1mM) was
incubated with 2mM of the different TPR deletion mutants in the
reaction buffer containing 50mM Tris–HCl, pH 7.5, 1mM DTT,
12.5mM MgCl2,1mCi of UDP-(
3H)GlcNAc (American Radiolabeled
Chemicals) for 90min at 371C. After the reaction, the peptides were
cleaned on a Sep-pak C18 cartridge (Waters Corp.) as follows: after
washing the cartridge with 10ml of methanol, 10ml of 50mM
formic acid, the reaction was then loaded, followed by washing
with 10ml of 50mM formic acid, 10ml of 50mM formic acid
containing 0.5M NaCl and 10ml of distilled H2O. The peptides were
eluted from the cartridge directly into scintillation vials with 2 
1.5ml of methanol. After drying off the methanol, the peptides were
resuspended in the scintillation ﬂuid and taken for counting.
The in vitro activity assays of wild-type and mutant hOGT with
10 mM recombinant TAB1 were carried out using the same reaction
conditions as for the peptide assay, in 20ml assay volumes. The
reactions were incubated for 90min at 371C, stopped by adding 4 
SDS–PAGE sample buffer, resolved on SDS–PAGE and after transfer
were taken for probing with antibodies.
The activity of the hOGT TPR truncation mutants was also tested
on the total cell lysate from HEK293 cells. The cell lysates (25mg)
were incubated with the enzymes in the standard reaction
conditions, subjected to SDS–PAGE followed by western blotting.
The loading controls were measured using b-tubulin antibodies
after stripping the blots following detection of O-GlcNAc signals.
For the XcOGTassays, A. thaliana lysate was prepared from cell
suspension culture in the buffer described earlier. After addition,
the buffer cells were sonicated for 30s and centrifuged at
14000r.p.m. for 10min and the supernatant was collected. For
the activity assay, the lysate was heat treated for 30min at 601C
before incubating 25mg of the lysate in a 20ml reaction buffer with
4mM UDP-GlcNAc and 5mMo fXcOGT. After 3h at 371C, the
reaction was stopped by adding SDS loading buffer and taken for
immunoblotting.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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